| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.3M | -3.4% |
| R&D Expense | $65.0M | -8.5% |
| SG&A Expense | $15.9M | -20.8% |
| Operating Income | -$77.0M | +11.5% |
| Net Income | -$72.5M | +16.6% |
| EPS (Basic) | -$6.07 | -1456.4% |
| EPS (Diluted) | -$6.07 | -1456.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.0M | -75.8% |
| Accounts Receivable | $716K | -49.4% |
| Current Assets | $13.5M | -70.6% |
| Total Assets | $27.7M | -53.9% |
| Current Liabilities | $38.4M | +28.7% |
| Stockholders' Equity | -$23.9M | -245.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.0M | +22.6% |
| Investing Cash Flow | -$262K | +80.7% |
| Financing Cash Flow | $30.8M | -51.4% |